Compare Humana Inc (HUM) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Sezzle Inc — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Sezzle Inc trades at $118.49 (market cap $3.83B). The key difference: Humana Inc is far larger — about 12.4× Sezzle Inc's market cap, and Humana Inc pays a 0.89% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Sezzle Inc for 15 Days on average.
| HUM | SEZL | |
|---|---|---|
Market Cap | $47.61B | $3.83B |
Volume | 1,827,332 | 341,401 |
Sector | Health | Financials |
52-Week High | $409.85 | $188.55 |
52-Week Low | $163.67 | $50.97 |
Typical Hold Time | 53 Days | 15 Days |
Enterprise Value | $54.97B | $3.88B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Sezzle (SEZL) trades at $113.85, up 0.9% with a bullish technical outlook supported by strong moving averages and ADX signals. The company demonstrates exceptional profitability with 30.35% net margins and 88.85% ROE, having beaten earnings estimates for three consecutive quarters. Recent product launches including Sezzle Send and SezzleCash are driving user growth and platform engagement.
With 67% analyst buy ratings and a $168 consensus price target suggesting 48% upside, SEZL presents growth potential despite competitive BNPL pressures. Key risks include sector volatility and execution challenges in scaling new products. The stock's current valuation at 24.97 P/E appears reasonable given its growth trajectory and profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
